Award winning Medtech firm excels again

Founded in 2014, MV.Health is a trusted global leader in clinical-grade medical devices transforming urological and gynaecological health. Their doctor-designed products adapt to the user’s anatomy and address various sexual dysfunctions.

Historically, the stigma and fear of invasive clinical procedures have deterred men from seeking proactive prostate care. MV.Health’s breakthrough Molto device won this year’s King’s Award for Enterprise in Innovation for fundamentally shifting this paradigm by making targeted, evidence-based prostate health management highly accessible from the comfort and privacy of home. Backed by rigorous clinical trials and published in leading medical journals, Molto provides vital, non-pharmacological relief for conditions like chronic prostatitis and delayed ejaculation, ultimately restoring patient confidence and daily comfort.

Driven by a mission to break the silence surrounding Uro/Gyn health, MV.Health’s doctor-designed devices have been published in 25 peer-reviewed journals including Nature and Journal of Sexual Health. They have won over 60 international medtech & business awards.

MV devices are recommended by leading doctors in US, UK & Europe and have improved the lives of over 250,000 patients.

By empowering individuals to safely and privately manage their health at home, MV.Health is driving early clinical intervention, improving systemic healthcare economics, and ultimately reducing the long-term risks associated with prostate conditions.